Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Gynecological gel for preventing and inhibiting HPV viruses

An HPV virus and gynecological technology, applied in the field of gynecological gel for preventing and inhibiting HPV virus, can solve problems such as large side effects and affect the effect of drugs, achieve good anti-virus, improve body immunity, and improve the effect of wound healing and regeneration.

Inactive Publication Date: 2018-04-27
杨平芝
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, the treatment techniques for gynecological diseases caused by HPV virus include: injection intramuscular injection, oral medicine, surgery, etc. These methods have relatively large side effects on the human body; some medicines are mainly administered through the vagina, and the formulations of vaginal administration preparations are commonly used There are mainly suppositories, gels, effervescent tablets, vaginal tablets, lotions, capsules, films, etc., but these dosage forms have more or less defects that affect the function of the drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] A gynecological gel for preventing and inhibiting HPV virus, including the following components in parts by weight: 0.2 parts of sodium hyaluronate, 10 parts of bitter bean extract, 5 parts of mugwort leaf extract, 2 parts of wild chrysanthemum extract, Radix isatidis 2 parts of extract, 2 parts of astragalus extract, 5 parts of Coptis extract, 2 parts of mannitol, 0.5 part of carbomer, 0.4 part of triethanolamine, 40 parts of water.

[0031] A method for preparing gynecological gel for preventing and inhibiting HPV virus, the method steps are as follows:

[0032] S1: Add water to the homogenizing emulsification pot and raise the temperature to 90°C, keep the temperature for 30min, add mannitol and carbomer, stir and dissolve evenly, then cool to 45°C;

[0033] S2: Add plant extracts and sodium hyaluronate into the emulsifying pot, stir and dissolve evenly, and then cool to 50°C;

[0034] S3: Add triethanolamine and stir for 30 minutes until the solution is completely uniform; ...

Embodiment 2

[0036] A gynecological gel for preventing and inhibiting HPV virus, including the following components in parts by weight: 0.5 parts of sodium hyaluronate, 15 parts of bitter bean extract, 10 parts of mugwort leaf extract, 7 parts of wild chrysanthemum extract, Radix isatidis 7 parts of extract, 7 parts of astragalus extract, 10 parts of Coptis extract, 5 parts of mannitol, 1.5 parts of carbomer, 0.8 parts of triethanolamine, 70 parts of water.

[0037] A method for preparing gynecological gel for preventing and inhibiting HPV virus, the method steps are as follows:

[0038] S1: Add water to a homogenizing emulsification pot and raise the temperature to 95°C, keep it for 30 minutes, add mannitol and carbomer, stir to dissolve evenly, and then cool to 50°C;

[0039] S2: Add plant extracts and sodium hyaluronate into the emulsifying pot, stir and dissolve evenly, then cool to 45°C;

[0040] S3: Add triethanolamine and stir for 30 minutes until the solution is completely uniform; it is r...

Embodiment 3

[0042] A gynecological gel for preventing and inhibiting HPV virus, comprising the following components in parts by weight: 0.3 parts of sodium hyaluronate, 12 parts of bitter bean extract, 7 parts of mugwort leaf extract, 5 parts of wild chrysanthemum extract, Radix isatidis 5 parts of extract, 5 parts of astragalus extract, 8 parts of Coptis extract, 3 parts of mannitol, 1.0 part of carbomer, 0.6 part of triethanolamine, and 60 parts of water.

[0043] A method for preparing gynecological gel for preventing and inhibiting HPV virus, the method steps are as follows:

[0044] S1: Add water to the homogenizing emulsification pot and raise the temperature to 93°C, keep the temperature for 30min, add mannitol and carbomer, stir and dissolve evenly, then cool to 42°C;

[0045] S2: Add plant extracts and sodium hyaluronate into the emulsifying pot, stir and dissolve evenly, then cool to 47°C;

[0046] S3: Add triethanolamine and stir for 30 minutes until the solution is completely uniform;...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses gynecological gel for preventing and inhibiting HPV viruses. The gynecological gel comprises sodium hyaluronate, extract of bitter bean, extract of argyle leaf, extract of wildchrysanthemum, extract of radix isatidis, extract of Astragalus mongholicus, extract of coptis root, mannitol, Carbomer, triethanolamine and water. The gynecological gel for preventing and inhibitingHPV viruses contains extract of multiple types of plants, does not stimulate the vagina, is safe and has no side effect. The sodium hyaluronate in the gel carries antiviral and antibacterial components which can fast penetrate into the skin and prevents mucous cells from being damaged by viruses. The gynecological gel can fast repair the skin tissue and improve the wound healing and regenerativecapacity. The extract of multiple types of plants in the gel can improve immunity and produce good antiviral effects. The experiment result shows that the gynecological gel has an effective rate of 91.1% to the low-risk HPV infection and an effective rate of 86.1% to the high-risk HPV infection.

Description

Technical field [0001] The invention relates to the technical field of daily chemicals, in particular to a gynecological gel for preventing and inhibiting HPV virus. Background technique [0002] Human Papillomavirus (HPV) is an epithelial virus with high specificity. HPV is known to cause benign tumors and warts in humans, such as human vulgaris, condyloma acuminata, and papilloma that grow on the mucous membranes near the reproductive organs. [0003] HPV is a kind of DNA virus, which is a general term for a group of viruses. It can be divided into many subtypes in clinical practice, and different subtypes can cause different diseases. According to different types of HPV and the risk of tumor occurrence, HPV can be divided into low-risk types and high-risk types. Low-risk types of HPV include HPV6, 11, 42, 43, 44, etc., and often cause benign lesions such as genital warts, including cervical intraepithelial low-grade lesions (CIN I). High-risk HPV includes HPV16, 18, 31, 33, 3...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/489A61K36/718A61K9/06A61P31/20
CPCA61K9/0034A61K9/06A61K36/195A61K36/282A61K36/287A61K36/315A61K36/481A61K36/489A61K36/718A61K47/36A61K2300/00
Inventor 杨平芝
Owner 杨平芝
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com